GLP1R and hyperinsulinism: The exact reasons behind the weaker response to GLP-1R agonists in people with diabetes compared to those without diabetes are not fully understood, but there are some possible explanations: a) People with type 2 diabetes have hyperinsulinemia (due to insulin resistance), a condition that can promote fat storage and reduce fat breakdown.